Stanford deploys 37,000 AI agents for therapy discovery

This demonstrates significant AI-driven advancement in biotechnology for accelerating therapy discovery, highlighting both potential benefits and the need for oversight.

Auto-scored: Risk is minor as it frames capability without misuse, while mitigation is substantive for scientific progress.